NEPHROCARE HEALTH SERV L DCF Valuation

NEPHROPLUS · Healthcare Services · Current price ₹635.7

Full stock page
DocStoX fair value
₹221
low confidence
Intrinsic-value estimate
₹107
9% ROE fading to 12% over ~3 yrs, on ₹111 book
Current price
₹636
Economic moat
None
Medium uncertainty
5Y profit growth
+138.4%
Model it yourself — DCF Calculator
Opens pre-filled with NEPHROCARE HEALTH SERV L's latest numbers.

NEPHROCARE HEALTH SERV L intrinsic-value estimate

Our intrinsic-value model estimates NEPHROCARE HEALTH SERV L is worth ₹107 per share, based on 9% ROE fading to 12% over ~3 yrs, on ₹111 book. Rather than a raw DCF — which is highly sensitive to fragile cash-flow forecasts — we use a residual-income (excess-return) model: a company is worth its book value plus the present value of the returns it earns ABOVE its cost of equity. A none economic moat sets how long that edge is assumed to last.

Try your own assumptions

Prefer a classic discounted-cash-flow view? Open the DCF calculator below — it pre-fills NEPHROCARE HEALTH SERV L's real free cash flow, net debt and share count so you can model your own growth and discount-rate scenario in seconds.

More on NEPHROCARE HEALTH SERV L

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.